Coors Biomedical Company – Trademark Portfolio

Entity Type: 03

Coors Biomedical Company holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 3 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include OSTEOGRAF. The owner is based in Lakewood, CO.

Suite 210

12860 W. Cedar Dr.

Lakewood, CO 80228

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Coors Biomedical Company's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (3 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Coors Biomedical Company have?

Coors Biomedical Company has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 cancelled.

What trademark classes does Coors Biomedical Company file in?

Coors Biomedical Company files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Coors Biomedical Company's most well-known trademarks?

Coors Biomedical Company's registered trademark portfolio includes well-known marks such as OSTEOGRAF. These are among 1 currently registered trademark in the portfolio.

What is Coors Biomedical Company's trademark registration success rate?

Coors Biomedical Company has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.